Orphan Drug Consulting supports companies in developing and bringing treatments to market. We provide expert guidance in regulatory affairs, quality assurance, supply chain management, and commercialisation, ensuring that life-changing therapies reach patients in need efficiently and compliantly.
Cooperation possibilities
We offer collaboration opportunities in regulatory strategy, clinical development, supply chain optimisation, and market access for orphan drugs. By partnering with biotech, pharma, we can accelerate the delivery of innovative treatments to patients with rare diseases.
- http://www.orphandrugconsulting.com
- +353871932222
- ericacoen@orphandrugconsulting.com
- Erica Coen
Some insights
Orphan Drug Consulting makes the world a better place by helping companies bring treatments to patients who often have limited or no treatment options, efficiently and compliantly, through regulatory guidance, quality assurance, supply chain management, and commercialisation strategies.
Working at Orphan Drug Consulting means directly impacting patients with rare diseases by bringing life-changing treatments to market. I grow professionally in a supportive environment while contributing to meaningful projects, knowing my work makes a real difference in people's lives.
Role models in the RD space include Henri Termeer (Genzyme), who helped change rare disease treatment, and John Crowley (Amicus Therapeutics), who turned a personal mission into biotech innovation. Leaders like Vasant Narasimhan (Novartis) also push for better rare disease research and access.
Orphan Drug Consulting’s team excels in regulatory expertise, quality assurance, supply chain, market access, and commercialisation. Looking ahead, we’re eager to integrate more partnership supports, and help with acquisition readiness for clients to increase their organisation's value.
My parents might say I help get life-changing medicines to people with rare diseases. They’d see me working with experts to navigate rules, ensure quality, and get treatments to patients who need them—making a real difference in people’s lives every day!
The Swiss biotech ecosystem can support us by fostering collaborations, sharing regulatory insights, and supporting networking. Access to funding, talent, and cutting-edge research helps accelerate orphan drug development, ensuring life-changing therapies reach patients faster.
We’d love to connect with biotech innovators, pharma leaders, regulatory experts, patient advocacy groups, and investors. People within technical operations functions or people at C-suite level for strategic guidance.